The latest financial statement is for the quarter ending 2025-09-30.
| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net loss | -22,795 | -67,175 |
| Depreciation, amortization, and impairment | 12,941 | 51,302 |
| Inventory reserve expenses | 2,383 | 25,393 |
| Amortization of operating lease assets, debt costs, and other assets | 1,582 | 2,377 |
| Provision for expected credit losses | 629 | 1,837 |
| Deferred income taxes | 321 | 12 |
| Share-based compensation expense | 7,181 | 14,293 |
| Loss on disposal of fixed assets | -280 | -581 |
| Change in valuation of investment securities | 10 | 31 |
| Change in fair value of contingent consideration | -427 | -1,373 |
| Other | -2,315 | 1,188 |
| Accounts receivable | 1,958 | -5,089 |
| Inventories | 3,579 | 5,890 |
| Prepaid expenses and other current assets | -1,191 | 394 |
| Accounts payable | 3,482 | -9,138 |
| Other current liabilities | 12,711 | -21,763 |
| Contingent consideration milestone payment | 1,340 | - |
| Other long-term assets and liabilities | 2,505 | 684 |
| Net cash provided by operating activities | 12,402 | -6,752 |
| Capital expenditures | 9,904 | 13,845 |
| Other investing activities | -10 | -12 |
| Net cash used in investing activities | -9,894 | -13,833 |
| Proceeds from issuance of common shares | 36 | 3,054 |
| Payments related to tax withholdings for share-based compensation | 9 | 159 |
| Payments related to finance lease obligation | 189 | 375 |
| Contingent consideration milestone payment | 4,990 | - |
| Payment of debt issuance costs and other financing activities | 0 | 531 |
| Net cash provided by (used in) financing activities | -5,152 | 1,989 |
| Effect of exchange rate changes on cash | -99 | 1,547 |
| Net change in cash and cash equivalents | -2,743 | -17,049 |
| Cash and cash equivalents at beginning of period | 85,738 | - |
| Cash and cash equivalents at end of period | 65,946 | - |
Orthofix Medical Inc. (OFIX)
Orthofix Medical Inc. (OFIX)